Home › Compare › QNNTF vs GBDC

QNNTF vs GBDC: Dividend Comparison 2026

QNNTF yields 2000.00% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 QNNTF wins by $9939315137.76M in total portfolio value
10 years
QNNTF
QNNTF
● Live price
2000.00%
Share price
$0.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9939315158.53M
Annual income
$9,049,252,674,478,578.00
Full QNNTF calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — QNNTF vs GBDC

📍 QNNTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodQNNTFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, QNNTF + GBDC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
QNNTF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QNNTF
Annual income on $10K today (after 15% tax)
$170,000.00/yr
After 10yr DRIP, annual income (after tax)
$7,691,864,773,306,791.00/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, QNNTF beats the other by $7,691,864,759,375,917.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QNNTF + GBDC for your $10,000?

QNNTF: 50%GBDC: 50%
100% GBDC50/50100% QNNTF
Portfolio after 10yr
$4969657589.65M
Annual income
$4,524,626,345,433,921.00/yr
Blended yield
91.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

QNNTF
No analyst data
Altman Z
-79.6
Piotroski
4/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QNNTF buys
0
GBDC buys
0
No recent congressional trades found for QNNTF or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricQNNTFGBDC
Forward yield2000.00% ✓11.85%
Annual dividend / share$2.00 ✓$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1% ✓
Portfolio after 10y$9939315158.53M ✓$20.78M
Annual income after 10y$9,049,252,674,478,578.00 ✓$16,389,263.41
Total dividends collected$9876141646.27M ✓$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: QNNTF vs GBDC ($10,000, DRIP)

YearQNNTF PortfolioQNNTF Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$210,700$200,000.00$12,490$1,790.28+$198.2K → QNNTF
2$4,163,767$3,938,317.76$16,522$3,157.73+$4.15M → QNNTF
3$77,191,133$72,735,902.82$23,578$5,898.68+$77.17M → QNNTF
4$1,342,813,676$1,260,219,163.76$37,115$11,886.75+$1342.78M → QNNTF
5$21,925,333,121$20,488,522,486.99$66,136$26,423.57+$21925.27M → QNNTF
6$336,109,296,351$312,649,189,912.21$137,257$66,491.44+$336109.16M → QNNTF
7$4,838,913,266,619$4,479,276,319,522.88$341,734$194,868.54+$4838912.92M → QNNTF
8$65,446,276,951,058$60,268,639,755,775.59$1,050,788$685,133.02+$65446275.90M → QNNTF
9$831,834,097,245,644$761,806,580,908,011.90$4,099,314$2,974,971.01+$831834093.15M → QNNTF
10$9,939,315,158,531,418$9,049,252,674,478,578.00$20,775,530$16,389,263.41+$9939315137.76M → QNNTF

QNNTF vs GBDC: Complete Analysis 2026

QNNTF — Stock

Quantum Genomics Société Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases. It develops drugs based on brain aminopeptidase A inhibition (BAPAI) platform primarily to treat high blood pressure and heart failure. The company develops firibastat, a monotherapy drug that is in pivotal Phase III study for the treatment of hypertension, as well as in clinical trial for the treatment of heart failure. It is also developing QGC011 to treat hypertension with combination therapy; and QGC006 and QGC606 drug for the treatment of hypertension and heart failure. The company was incorporated in 2005 and is based in Paris, France.

Full QNNTF Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this QNNTF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QNNTF vs SCHDQNNTF vs JEPIQNNTF vs OQNNTF vs KOQNNTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.